COPENHAGEN: The WHO on Thursday slammed Europe’s “unacceptably slow” vaccine rollout, warning of a worrying surge in cases as France became the latest country to impose new restrictions to combat mounting infections.

As European nations scrambled to contain third waves across the continent, Brazil marked a grim milestone with more than 66,000 deaths in March — by far the highest since the beginning of the pandemic.

On the vaccine front there was a glimmer of hope as Pfizer/BioNTech said their jab was highly effective against the South African variant, and Israel vowed to inoculate children after promising trial data among youngsters.

Governments are hoping vaccines will be the route to a return to normal more than a year into the pandemic that has now killed more than 2.8 million people and subjected much of humanity to punishing restrictions.

But Europe has struggled with its vaccine drive, and the World Health Organisation (WHO) said the sluggish pace is prolonging the pandemic.

“Vaccines present our best way out of this pandemic... however, the rollout of these vaccines is unacceptably slow,” said WHO director for Europe Hans Kluge.

“We must speed up the process by ramping up manufacturing, reducing barriers to administering vaccines, and using every single vial we have in stock.”

The EU has blamed supply problems on its sluggish rollout, but several nations are also facing high rates of vaccine hesitancy, even in the face of rising infections.

Italy has fallen dramatically short of its vaccine targets after receiving almost 30 percent fewer doses than expected, data showed.

Only 10 percent of Europe’s total population have received one vaccine dose, and four percent have received two, WHO said.

By comparison, world leader Israel has already given two shots to more than half of its population, while in the US close to 16 percent of the population has received both.

Israel said it plans to expand its vaccine campaign to children aged 12 to 15 from May, after a study showed its efficacy for the age group.

It is using jabs from Pfizer/BioNTech, which on Thursday released promising new data showing it was highly effective against the South African variant of the virus that has ravaged that country.

No cases of the disease were observed in South Africa during a phase-three trial study among participants who had received a second dose, the companies said.

But as some nations looked to a post-pandemic reality, others were mired in fresh anti-virus measures.

A surge of infections in France forced President Emmanuel Macron to reimpose nationwide restrictions he rejected in January.

“We gained precious weeks of liberty,” he said in a national address late on Wednesday, but the current measures “were too limited at a time when the epidemic is accelerating”.

The limited lockdown already in place in regions, including Paris, would be extended to the whole country from Saturday night for the next four weeks, he said.

Schools will close for three or four weeks depending on age level, and alcoholic drinks will be prohibited in parks and other outdoor public spaces.

Published in Dawn, April 2nd, 2021